Ventyx Biosciences (VTYX) announced the appointment of industry veteran Matthew Moore as Chief Operating Officer, COO. Matt most recently served as the Chief Business Officer of Arcutis Biotherapeutics (ARQT), where he led corporate strategy, business development and project management functions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTYX:
- Ventyx Biosciences reports Q1 EPS (62c), consensus (67c)
- Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
- Ventyx Biosciences files to sell 11.17M shares of common stock for holders
- Class Action Lawsuit against Ventyx Biosciences, Inc. (NASDAQ:VTYX)
- Ventyx Biosciences CBO Christopher Krueger Steps Down
Questions or Comments about the article? Write to editor@tipranks.com